Lannett Company, Inc. - stock earnings
Stock symbol LCI is outdated, potentially delisted? Maybe it is available on other exchange?
LCI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -36.3 million USD | 80.9 million USD |
| 2022Q3 | -28.0 million USD | 75.1 million USD |
| 2022Q2 | -93.3 million USD | 74.2 million USD |
| 2022Q1 | -34.9 million USD | 78.4 million USD |
| 2021Q4 | -81.1 million USD | 86.5 million USD |
| 2021Q3 | -22.3 million USD | 101.5 million USD |
| 2021Q2 | -177.9 million USD | 106.0 million USD |
| 2021Q1 | -7.1 million USD | 112.4 million USD |
| 2020Q4 | -171.9 million USD | 133.9 million USD |
| 2020Q3 | -6.5 million USD | 126.5 million USD |
| 2020Q2 | -9.7 million USD | 137.9 million USD |
LCI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -231.6 million USD | 340.6 million USD |
| 2021 | -363.5 million USD | 478.8 million USD |
| 2020 | -33.4 million USD | 545.7 million USD |
| 2019 | -272.1 million USD | 655.4 million USD |
| 2018 | 28.7 million USD | 684.6 million USD |
| 2017 | -581000 USD | 637.3 million USD |
LCI
Price: $0.69
52 week price:
Dividend Yield: 3.41%
Payout Ratio Range:
Earnings Per Share: -5.44 USD
P/E Ratio: -0.22
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 771900
Ebitda: 66.4 millionMarket Capitalization: 9.9 million